Cargando…
Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
Background and purpose: Gambogic acid (GA) is a natural compound that exhibited a promising multi-target antitumor activity against several types of cancer. However, the clinical application of this drug is limited due to its poor solubility and low tumor cell-specific delivery. In this study, the m...
Autores principales: | Kebebe, Dereje, Wu, Yumei, Zhang, Bing, Yang, Jian, Liu, Yuanyuan, Li, Xinyue, Ma, Zhe, Lu, Peng, Liu, Zhidong, Li, Jiawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683963/ https://www.ncbi.nlm.nih.gov/pubmed/31447559 http://dx.doi.org/10.2147/IJN.S202424 |
Ejemplares similares
-
Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
por: Huang, Rui, et al.
Publicado: (2018) -
Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment
por: Liu, Yuling, et al.
Publicado: (2023) -
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
por: Kebebe, Dereje, et al.
Publicado: (2018) -
Research progress of in-situ gelling ophthalmic drug delivery system
por: Wu, Yumei, et al.
Publicado: (2019) -
Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers
por: Yan, Hongli, et al.
Publicado: (2019)